| Disease | SCORE AND ATTENTION SPAN COMPARED WITH THE CASE OF PARTICIPANTS RECEIVING NO TREATMENT. HRT AND PL HAD EFFECTS ON COGNITIVE FUNCTION; HRT IMPROVED DELAYED RECALL, WHEREAS FLEXIBLE THINKING SEEMED IMPROVED IN THE PL GROUP.
NO SIGNIFICANT CHANGES IN LIPID PROFILE OR FOLLICLE-STUMULATING HORMONE AND LUTEINIZING HORMONE WERE OBSERVED IN THE PL GROUP COMPARED WITH THE CONTROLS. HOWEVER, BOTH THE HRT AND PL GROUPS SHOWED AN IMPROVEMENT IN MINI-MENTAL STATE EXAMINATION
ESTRADIOL; FOLLICLE-STIMULATING HORMONE; AND LEUTEINZING HORMONE. ONLY PARTICIPANTS IN THE HRT GROUP SHOWED A MEAN REDUCTION IN CHOLESTEROL AND LOW-DENSITY LIPOPROTEIN CHOLESTEROL THAT WAS SIGNIFICANTLY DIFFERENT FROM THAT OF THE CONTROL GROUP.
SYMPTOMS QUESTIONNAIRE; NEUROPSYCHOLOGICAL TESTS COVERING MEMORY, ATTENTION, MOTOR SPEED, AND WORD-FINDING ABILITY; QUALITY OF LIFE(SF36); LIPID PROFILE; URINARY DEOXYPYRIDNOLINE; DIETARY PHYTOESTEROGEN INTAKE AND URINARY PHYTOESTEROGEN;
50 TO 65 YEARS WERE RANDOMIZED TO RECEIVE HRT(N=43), PL(EQUIVALANT TO 100 MG ISOFLAVONE; N=45), OR NO TREATMENT (N=39) FOR 3 MONTHS. THE FOLLOWING MEASURMENTS WERE CARRIED OUT AT BASELINE AND AFTER 3 MONTHS FOR ALL THE PARTICIPANTS: MENOPAUSAL
TO EXAMINE THE EFFECTS OF PL IN COMPARISION WITH HORMONE REPLACEMENT THERAPY(HRT) ON THE LIPID PROFILE, SEX HORMONE LEVELS, BONE TURNOVER MARKERS, AND INDICES OF COGNITIVE FUNCTION. IN THE STUDY, 127 COMMUNITY-LIVING, POSTMENOPAUSAL WOMEN AGED |